Original Article

You have full text access to this OnlineOpen article

Treatment and survival outcomes in young men diagnosed with prostate cancer†

A Population-based Cohort Study

  1. Daniel W. Lin MD1,
  2. Michael Porter MD1,
  3. Bruce Montgomery MD2,‡,*

Article first published online: 22 MAY 2009

DOI: 10.1002/cncr.24324

Issue

Cancer

Cancer

Volume 115, Issue 13, pages 2863–2871, 1 July 2009

Additional Information

How to Cite

Lin, D. W., Porter, M. and Montgomery, B. (2009), Treatment and survival outcomes in young men diagnosed with prostate cancer. Cancer, 115: 2863–2871. doi: 10.1002/cncr.24324

Author Information

  1. 1

    Department of Urology, Virginia Puget Sound Health Care System, University of Washington, Northwest Prostate Cancer Specialized Program of Research Excellence, Seattle, Washington

  2. 2

    Department of Medicine, Virginia Puget Sound Health Care System, University of Washington, Northwest Prostate Cancer Specialized Program of Research Excellence, Seattle, Washington

  1. ‡

    Fax: (206) 764-2851

*Veterans Administration Puget Sound Health Care System, 1660 South Columbian Way (111ONC), Seattle, WA 98108

  1. †

    This article is a US Government work and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 19 JUN 2009
  2. Article first published online: 22 MAY 2009
  3. Manuscript Accepted: 8 DEC 2008
  4. Manuscript Revised: 3 DEC 2008
  5. Manuscript Received: 22 JUL 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (247K)

References

  • 1
    Bleyer A. Young adult oncology: the patients and their survival challenges. CA Cancer J Clin. 2007; 57: 242-255.
    Direct Link:
  • 2
    Kotsis SV,Spencer SL,Peyser PA,Montie JE,Cooney KA. Early onset prostate cancer: predictors of clinical grade. J Urol. 2002; 167: 1659-1663.
  • 3
    Khan MA,Han M,Partin AW,Epstein JI,Walsh PC. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology. 2003; 62: 86-91; discussion 91–92.
  • 4
    Rosser CJ,Chichakli R,Levy LB,Kuban DA,Smith LG,Pisters LL. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation. J Urol. 2002; 168: 536-541.
  • 5
    Smith CV,Bauer JJ,Connelly RR, et al. Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database. J Urol. 2000; 164: 1964-1967.
  • 6
    Freedland SJ,Aronson WJ,Kane CJ, et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol. 2004; 22: 446-453.
  • 7
    Loeb S,Hernandez DJ,Mangold LA, et al. Progression after radical prostatectomy for men in their thirties compared to older men. BJU Int. 2008; 101: 1503-1506.
    Direct Link:
  • 8
    Arias E. United States life tables, 2004. Natl Vital Stat Rep. 2007; 56: 1-39.
  • 9
    de la Rochefordiere A,Asselain B,Campana F, et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet. 1993; 341: 1039-1043.
  • 10
    Aebi S,Gelber S,Castiglione-Gertsch M, et al. Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet. 2000; 355: 1869-1874.
  • 11
    Freedland SJ,Presti JC Jr,Kane CJ, et al. Do younger men have better biochemical outcomes after radical prostatectomy? Urology. 2004; 63: 518-522.
  • 12
    Ryan CJ,Elkin EP,Cowan J,Carroll PR. Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE. Cancer. 2007; 110: 81-86.
    Direct Link:
  • 13
    Kupelian PA,Reddy CA,Reuther AM,Mahadevan A,Ciezki JP,Klein EA. Aggressiveness of familial prostate cancer. J Clin Oncol. 2006; 24: 3445-3450.
  • 14
    Roupret M,Fromont G,Bitker MO,Gattegno B,Vallancien G,Cussenot O. Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology. 2006; 67: 1028-1032.
  • 15
    Tryggvadottir L,Vidarsdottir L,Thorgeirsson T, et al. Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst. 2007; 99: 929-935.
  • 16
    Edwards SM,Kote-Jarai Z,Meitz J, et al. Two percent of men with early onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet. 2003; 72: 1-12.
  • 17
    Perez-Gracia JL,Gloria Ruiz-Ilundain M,Garcia-Ribas I,Maria Carrasco E. The role of extreme phenotype selection studies in the identification of clinically relevant genotypes in cancer research. Cancer. 2002; 95: 1605-1610.
    Direct Link:
  • 18
    Kawachi MH,Bahnson RR,Barry M, et al. Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2007; 5: 714-736.
View Full Article (HTML) Get PDF (247K)